Primer: Shijiazhuang Yiling Pharmaceutical (002603 CH) - Aug 2026
Shijiazhuang Yiling Pharmaceutical is a leading player in China's Traditional Chinese Medicine (TCM) sector, with its flagship product, Lianhua...
92 Views
Index Rebalance & ETF Flow Recap: FRTIB, Japan, CSI300, CSI500, STAR50, WuXi XDC, Asahi
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
1.1k Views
China Reopen - Opportunities and Challenges in China Healthcare
As China restores normal production/life, we analyzed positive/negative impact on different healthcare sectors. There could be policy shifts. What...
549 Views
Russia-Ukraine War: The Impact on China Healthcare
We analyzed the potential impact of Russia-Ukraine war on China healthcare industry including the delay of clinical trial projects in Ukraine,...
478 Views
Falling Fertility Adds to China's Population Woes
By allowing couples to have up to two children China hopes to reverse its likely population decline. But falling fertility and the pressures of...
4.3k Views